升级调节减弱了KRAS-PI3K-Rac1-Akt轴介导的生物能量功能
Kuang-Chen Hung1,2,3, Ni Tien4, Da-Tian Bau5
1Division of Neurosurgery, Department of Surgery, Taichung Army Force General Hospital, Taichung 41152, Taiwan.
Cells
|September 28, 2023
概括
纳灵宁 (NGN) 向鼻癌 (NPC) 细胞中的KRAS-p110α相互作用,通过let-7g上调和MCPIP1抑制抑制糖解和线粒体OXPHOS,最终诱导亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 异常的信号通路激活驱动癌症代谢重编程.
- 针对信号调节器提供了一个有希望的癌症治疗策略.
研究的目的:
- 为了研究纳灵宁 (NGN) 对鼻癌 (NPC) 细胞的信号通路和代谢功能障碍的影响.
- 阐明KRAS,let-7g和MCPIP1在NGN诱导的亡中的作用.
主要方法:
- 采用了亚细胞分离,共免疫沉和生物化学分析.
- 使用let-7g模仿和抑制剂进行基因操纵.
- 实验的重点是脂质和MCPIP1核糖核酶活性.
主要成果:
- NGN降低了脂质中的KRAS-p110α相互作用,破坏了PI3K-Rac1-Akt信号传输.
- 这种干扰导致糖解和线粒体OXPHOS的代谢功能障碍,诱导NPC细胞的亡.
- 通过抑制MCPIP1-介导的降解,NGN上调了let-7g,抑制了瘤性KRAS信号传递.
结论:
- 通过向KRAS-PI3K-Akt轴和代谢途径,NGN有效地抑制NPC细胞的增殖.
- NGN-MCPIP1-let-7g相互作用对于调节细胞代谢和诱导NPC中的亡至关重要.
- 通过恢复代谢平衡,NGN代表了鼻癌的潜在治疗剂.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


